ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Lorlatinib in Frontline Therapy for ALK+ Advanced Non-Small-Cell Lung Cancer: Still a Matter of Debate?

Maurice Pérol et al.PubMed ↗Publisher ↗

No numbers read from the abstract.